PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-19

Date Title Company
19-Sep-2023 Precisia Life Sciences launched to provide new intelligence for targeted medicine design Precisia Life Sciences
19-Sep-2023 Peer-Reviewed Publication of Positive Preclinical Data of SiSaf’s SIS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis SiSaf Ltd
19-Sep-2023 Cell and Gene Therapy Catapult launches new network for the advanced therapies industry in Scotland Cell and Gene Therapy Catapult
19-Sep-2023 Interim Results for the Six Months ended 30 June 2023 Futura Medical plc
19-Sep-2023 Bloomsbury Genetic Therapies Announces Recent Publication of Three Articles Supporting the Preclinical Efficacy and Differentiation of BGT-OTCD as a Potential Treatment for Ornithine Transcarbamylase Deficiency (OTCD) Bloomsbury Genetic Therapies
19-Sep-2023 CPHI Barcelona announces Pharma Award finalists CPHI Barcelona
19-Sep-2023 BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia BioMarin
19-Sep-2023 Millions Missing Out On Essential Eye Care Eye Health UK
19-Sep-2023 Panthera bucks the trend and brings vaccine trials to the UK Panthera Biopartners
19-Sep-2023 EBGLYSS® (lebrikizumab) receives positive CHMP opinion for moderate-to-severe atopic dermatitis Almirall
19-Sep-2023 Transfer of ageing: New drug class prevents key ageing mechanism in organ transplants European Society for Organ Transplantation (ESOT)
19-Sep-2023 Neonatal kidney transplantation offers new hope in the organ shortage crisis, study shows European Society for Organ Transplantation (ESOT)
19-Sep-2023 Islet transplantation boosts long-term survival in kidney transplant recipients with type 1 diabetes European Society for Organ Transplantation (ESOT)
19-Sep-2023 ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development ImmunOs Therapeutics
19-Sep-2023 1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab) 1ST Biotherapeutics, Inc.
19-Sep-2023 Thermosome Establishes High-Profile Clinical Advisory Board Thermosome GmbH
19-Sep-2023 CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI CD ComputaBio
19-Sep-2023 CD ComputaBio Unveils Cutting-Edge Advances in Antibody Drug Design and Development CD ComputaBio